Collagen-binding activity of plasma vitronectin in chronic liver disease

Clinica Chimica Acta

Volumn 252, Issue 1, 1996, Pages 95-103

  Yamada, Sadako ^a   Kobayashi, Junko ^a   Murawaki, Yoshikazu ^a   Suou, Takeaki ^a   Kawasaki, Hironaka ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Chronic liver disease; Collagen; Vitronectin

Indexed keywords

COLLAGEN; VITRONECTIN;

ADULT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; FEMALE; HEPATITIS; HUMAN; HUMAN TISSUE; LIVER CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0030586982     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06320-6     Document Type: Article

References (17)

1. [1] Suzuki S, Pierschbacher MD, Hayman EG, Nguyen K, Ohgern Y, Ruoslahti E. Domain structure of vitronectin. J Biol Chem 1984;259:15307-15314.
2. [2] Barnes DW, van der Bosch J, Masui H, Miyazaki K, Sato G. The culture of human tumor cells in serum-free medium. Methods Enzymol 1981;79:368-369.
3. [3] Tshopp J, Masson D, Schafer S, Peitsch M, Preissner KT. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8 and C9 and perforin from cytolytic T-cells and inhibits their lytic activities. Biochemistry 1988;27:4103-4109.
4. [4] Jenne D, Stanley KK. Molecular cloning of S-protein, a link between complement, coagulation and cell substrate adhesion. EMBO J 1985;4:3153-3157.
5. [5] Inuzuka S, Ueno T, Torimura T et al. Vitronectin in liver disorders: Biochemical and immunohistochemical studies. Hepatology 1992;15:629-636.
6. [6] Yamada S, Kishimoto Y, Suou T, Kawasaki H, Horie Y. Heterogeneity of antigens related to 7S domain of type IV collagen in serum: application to patients with chronic liver disease. Clin Chim Acta 1992;212:73-78.
7. [7] Akama T, Yamada KM, Seno N et al. Immunological characterization of human vitronectin and its binding to glycosaminoglycans. J Biochem 1986;100:1343-1351.
8. [8] Grebb C, Hayman EG, Engvall E, Ruoslahti E. Interaction of vitronectin with collagen. J Biol Chem 1986;261:16698-16703.
9. [9] Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E. Complete amino acid sequence of human vitronectin deduced from cDNA similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 1985;4:2519-2524.
10. [10] Izumi M, Shimooka T, Morishita N, Ii I, Hayashi M. Identification of collagen-binding domain of vitronectin using monoclonal antibodies. Cell Struct Funct 1988;13:217-225.
11. [11] Kobayashi J, Yamada S, Kawasaki H. Distribution of vitronectin in plasma and liver tissue: relationship to chronic liver disease. Hepatology 1994;20:1412-1417.
12. [12] Clement B, Grimand JA, Campion JP, Deugneier Y, Guillouzo A. Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology 1986;6:225-234.
13. [13] Yamada S, Suou T, Kawasaki H, Yoshikawa N. Clinical significance of serum 7S collagen in various liver disease. Clin Biochem 1992;25:467-470.
14. [14] Murawaki Y, Ikuta Y, Koda M, Nishimura Y, Kawasaki H. Clinical significance of serum hyaluronan in patients with chronic viral liver disease. J Gastroenterol Hepatol 1996;11:in press.
15. [15] Ishikawa M, Hayashi M. Activation of the collagen-binding of endogenous serum vitronectin by heating, urea and glycosaminoglycans. Biochim Biophys Acta 1989;990:101-108.
16. [16] Jenne D, Hille A, Stanley KK, Huttner WB. Sulfation of two tyrosine residues in human complement S-protein (vitronectin). Eur J Biochem 1989;185:391-395.
17. [17] McGuire EA, Peacock ME, Inhorn RC, Siegel NR, Tollefsen DM. Phosphorylation of vitronectin by a protein kinase in human plasma. J Biol Chem 1988;263:1942-1945.